- Home
- QXO vs MEDP Comparison
QXO vs MEDP Comparison
Compare QXO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QXO
- MEDP
- Stock Information
- Founded
- QXO 1988
- MEDP 1992
- Country
- QXO United States
- MEDP United States
- Employees
- QXO N/A
- MEDP N/A
- Industry
- QXO EDP Services
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- QXO Technology
- MEDP Health Care
- Exchange
- QXO Nasdaq
- MEDP Nasdaq
- Market Cap
- QXO 13.2B
- MEDP 13.4B
- IPO Year
- QXO N/A
- MEDP 2016
- Fundamental
- Price
- QXO $17.16
- MEDP $585.82
- Analyst Decision
- QXO Strong Buy
- MEDP Hold
- Analyst Count
- QXO 12
- MEDP 11
- Target Price
- QXO $33.45
- MEDP $451.70
- AVG Volume (30 Days)
- QXO 7.9M
- MEDP 350.9K
- Earning Date
- QXO 11-06-2025
- MEDP 10-22-2025
- Dividend Yield
- QXO N/A
- MEDP N/A
- EPS Growth
- QXO N/A
- MEDP 25.36
- EPS
- QXO N/A
- MEDP 14.32
- Revenue
- QXO $4,662,873,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- QXO $12,779.57
- MEDP $21.48
- Revenue Next Year
- QXO $56.23
- MEDP $11.90
- P/E Ratio
- QXO N/A
- MEDP $41.14
- Revenue Growth
- QXO 8107.98
- MEDP 13.88
- 52 Week Low
- QXO $11.85
- MEDP $250.05
- 52 Week High
- QXO $24.69
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- QXO 39.90
- MEDP 62.02
- Support Level
- QXO $17.64
- MEDP $572.12
- Resistance Level
- QXO $18.85
- MEDP $602.54
- Average True Range (ATR)
- QXO 0.82
- MEDP 20.93
- MACD
- QXO -0.14
- MEDP -0.69
- Stochastic Oscillator
- QXO 36.90
- MEDP 59.40
About QXO QXO Inc. Common Stock
QXO Inc is a building products distribution company engaged in the distribution of roofing, waterproofing and complementary building products in North America. It offers a full suite of business applications, including ERP, warehouse management, accounting, CRM, and business intelligence solutions.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.